Obramin Eye Drop contains Tobramycin 0.3% w/v, an aminoglycoside antibiotic effective against a wide range of gram-negative and some gram-positive bacterial infections of the eye. It is primarily indicated for the treatment of bacterial conjunctivitis, keratitis, blepharitis, and other superficial ocular infections caused by susceptible strains. Tobramycin works by inhibiting bacterial protein synthesis, thereby exerting a bactericidal effect. Obramin Eye Drop is administered topically to the affected eye, allowing for targeted delivery and rapid therapeutic action with minimal systemic absorption. The formulation is sterile and designed to be isotonic to minimize ocular irritation. It is important to use the medication exactly as prescribed, typically instilling one to two drops into the conjunctival sac every four to six hours, depending on the severity of the infection. Patients should avoid contaminating the dropper tip and discontinue use if hypersensitivity or severe irritation occurs. Caution is advised in patients with known hypersensitivity to aminoglycosides. Obramin Eye Drop is contraindicated in viral, fungal, or mycobacterial ocular infections where antibiotic therapy is not appropriate. Proper hygiene and adherence to the prescribed regimen are essential to prevent resistance development and ensure effective resolution of the infection.